Search alternatives:
development programs » development goals (Expand Search)
Showing 3,901 - 3,920 results of 4,276 for search 'targeted development programs', query time: 0.20s Refine Results
  1. 3901

    Contextual Vulnerability Should Guide Fair Subject Selection in Xenotransplantation Clinical Trials by Gianna Strand

    Published 2023-03-01
    “…[xiii] Only 7 percent of renal transplant programs use formal criteria for subjective psychosocial assessments, while no pediatric solid organ transplant programs use formal, explicit, or uniform review to assess developmental delays and psychosocial support.…”
    Get full text
    Article
  2. 3902
  3. 3903

    Intratumoral STING agonist reverses immune evasion in PD-(L)1-refractory Merkel cell carcinoma: mechanistic insights from detailed biomarker analyses by Shailender Bhatia, Paul Nghiem, Rima Kulikauskas, Candice Church, David M Koelle, Lisa Tachiki, Kimberly Smythe, Thomas Pulliam, Shira Tabachnick-Cherny, Saumya Jani, Peter H Goff, Rashmi Bhakuni, Brandon W Seaton

    Published 2024-10-01
    “…The stimulator of interferon genes (STING) protein, an innate sensor of cytoplasmic DNA, is a promising target with several agonists in development. However, response rates in most recent clinical trials have been low and mechanisms of response remain unclear. …”
    Get full text
    Article
  4. 3904
  5. 3905

    Chronical kidney disease in clinical practice: non progredi est regredi (lat. not to go forward is to go back) by A. L. Vertkin, N. A. Burakova, Yu. V. Sedyakina, S. S. Kurdzhieva, M. M. Shamuilova, E. M. Ledeneva

    Published 2023-10-01
    “…Upon stabilization of the patient’s condition, she was discharged from the hospital with recommendations to continue the program hemodialysis. However, even upon admission to the hospital, the patient’s creatinine level was 260 μmol/L, which may indicate that chronic kidney disease had been developing for a long time before myocardial infarction and before the administration of X-ray contrast medium during coronary angiography.Conclusion. …”
    Get full text
    Article
  6. 3906
  7. 3907

    A novel key virulence factor, FoSSP71, inhibits plant immunity and promotes pathogenesis in Fusarium oxysporum f. sp. cubense by Shuang Liu, Junyu Wu, Yinhui Sun, Yun Xu, Siyu Zhou, Peiping Luo, Zhibiao Wang, Daipeng Chen, Xiaofei Liang, Zhensheng Kang, Li Zheng

    Published 2025-05-01
    “…The Foc4 mutant lacking FoSSP71 showed significantly reduced pathogenicity toward bananas, demonstrating that FoSSP71 is a potential target for controlling banana wilt disease. These findings provide a scientific basis for breeding banana varieties resistant to wilt disease and for developing new disease control strategies, which are crucial for the sustainable development of the global banana industry.…”
    Get full text
    Article
  8. 3908
  9. 3909
  10. 3910

    Gene polymorphism of aldosterone synthetase (CYP11B2) variants and main cardiovascular risk factors by L. Ye. Lobach, V. Ye. Dosenko, M. M. Dolzhenko

    Published 2016-12-01
    “…Statistical analysis of the results was performed using Microsoft Excel, the statistical program SPSS (version 13US). Results. When analyzing the average levels of low density lipoprotein (LDL) cholesterol statistically significant difference between the group of patients with postinfarction cardiosclerosis and the group of high-risk patients (2.93±1.2 mmol/L vs 3.4±1.2 mmol/L, p=0.0075) was demonstrated, indicating a better cholesterol control in the group of patients with postinfarction cardiosclerosis, despite the fact that the average cholesterol level did not reach the target. …”
    Get full text
    Article
  11. 3911

    Cuproptosis: a novel therapeutic mechanism in lung cancer by Cheng Luo, Xinhui Wu, Shipeng Zhang, Junwen Tan, Yuzhi Huo, Xinyue Zhang, Bo Ning, Yuanhang Ye, Fei Wang

    Published 2025-06-01
    “…Unlike pyroptosis and necroptosis, cuproptosis is a non-apoptotic programmed cell death process. Studies have demonstrated that cuproptosis is involved in the incidence, development, and metastasis of lung cancer. …”
    Get full text
    Article
  12. 3912
  13. 3913
  14. 3914
  15. 3915

    A new approach in prevention and correction of intradialysis hypotension in patients on maintenance hemodialysis by I. Yu. Drachev, V. Yu. Shilo, G. S. Dzhulay

    Published 2018-12-01
    “…However, when automatic pressure monitoring system was used in patients, the target phosphate levels were achieved: the inorganic phosphorus value was 1.5 mmol/L when using the UF control algorithm vs. 1.8 mmol/L with a standard dialysis program. …”
    Get full text
    Article
  16. 3916
  17. 3917

    The gut microbiota mediates protective immunity against tuberculosis via modulation of lncRNA by Fang Yang, Yi Yang, Lingming Chen, Zhiyi Zhang, Linna Liu, Chunmin Zhang, Qiongdan Mai, Yiwei Chen, Zixu Chen, Tao Lin, Liang Chen, Huixin Guo, Lin Zhou, Hongbo Shen, Xinchun Chen, Lei Liu, Guoliang Zhang, Hongying Liao, Lingchan Zeng, Gucheng Zeng

    Published 2022-12-01
    “…The gut-lung axis has been implicated as a potential therapeutic target in lung disorders. While increasing evidence suggests that gut microbiota plays a critical role in regulating host immunity and contributing to tuberculosis (TB) development and progression, the underlying mechanisms whereby gut microbiota may impact TB outcomes are not fully understood. …”
    Get full text
    Article
  18. 3918
  19. 3919

    Inhibiting CMTM4 reverses the immunosuppressive function of myeloid-derived suppressor cells and augments immunotherapy response in cervical cancer by Bo Yin, Wei Wang, Ang Li, Mengjie Li, Huijuan Zhou, Haoran Hu, Jianyi Ding, Yashi Zhu, Xinxin Xu, Meiqin Yang, Tiefeng Huang, Yifan Kou, Zilale Rahim, Baoyou Huang, Lingfei Han

    Published 2025-06-01
    “…Mechanistically, CMTM4 interacts and stabilizes PHB2 (prohibitin 2) through post-translational modification, which further induces activation of the STING (stimulator of interferon genes)/TBK1 (TANK-binding kinase 1)/STAT6 (signal transducer and activator of transcription 6) pathway, facilitating the nuclear translocation of STAT6 which binds to the CCL2/IL-6 promoter, leading to the upregulation of CCL2/IL-6 transcription expression. Importantly, targeting CMTM4 with CMTM4-small interfering RNA enhanced the effectiveness of anti-programmed cell death protein 1 (anti-PD-1) therapy. …”
    Get full text
    Article
  20. 3920